Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review

Since sorafenib was introduced in 2007 for treating advanced hepatocellular carcinoma (HCC), 15 patients have achieved a complete response (CR) in advanced HCC. However, only four of these reports can be regarded as real CRs involving adequate assessments including imaging, serum tumor markers, and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Mol Hepatol
Autores principales: Kim, Tae Suk, Kim, Ji Hoon, Kim, Baek hui, Lee, Young-Sun, Yoo, Yang Jae, Kang, Seong Hee, Suh, Sang-June, Jung, Young Kul, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Association for the Study of the Liver 2017
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5760007/
https://ncbi.nlm.nih.gov/pubmed/28633200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0070
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares